About 260 Mg Paclitaxel Injection IP
Experience the remarkable efficacy of Paclitaxel Injection IP 260 mg - famed for its potent cancer-fighting action and lavish safety profile. This prescription-only formulation is available at the best price and is an ideal choice for hospitals seeking the lowest price without compromising quality. Utilise our offer and secure this preservative-free, sterile, and single-use vial for a range of solid tumors, including ovarian, breast, and non-small cell lung cancers. Each 43.4 ml vial is compatible with non-PVC infusion sets and should be diluted before intravenous administration. Store below 25C and protect from light for optimal shelf life of 24 months. Distributed, exported, and supplied by trusted providers across India.
Advanced Treatment for Multiple Cancers
Paclitaxel Injection IP 260 mg is widely used as a chemotherapeutic agent for treating ovarian cancer, breast cancer, non-small cell lung cancer, and other solid tumors. Its application is strictly intravenous, making it a cornerstone in advanced hospital oncology care. Key features include a preservative-free, non-pyrogenic vial, ensured compatibility with non-PVC infusion sets, and precise dilution as directed by professionals. This reliable solution offers clear, colorless to pale yellow viscous administration for effective cancer management.
Reliable Export, Certifications & Seamless Shipping
Shipped goods are efficiently dispatched from reliable FOB ports in India. The product holds necessary certifications, ensuring international quality and compliance. Order completion is streamlined with clear payment terms and the promise of quick dispatch. Medical distributors, exporters, suppliers, and traders can count on timely, secure packaging and consistent supply, safeguarding seamless delivery to healthcare providers seeking excellence and dependability in oncology treatments.
FAQ's of 260 Mg Paclitaxel Injection IP:
Q: How should Paclitaxel Injection IP 260 mg be administered?
A: Paclitaxel Injection IP 260 mg must be administered intravenously, after proper dilution according to medical instructions, by healthcare professionals in a hospital setting.
Q: What cancers is this injection indicated for?
A: This injection is indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and other specified solid tumors.
Q: What are the storage instructions for this product?
A: Paclitaxel Injection IP 260 mg should be stored below 25C and protected from light to maintain its effectiveness throughout its 24-month shelf life.
Q: Is this injection compatible with all infusion sets?
A: No, it is specifically compatible with non-PVC infusion sets, as per its formulation requirements.
Q: What safety precautions need to be taken during handling?
A: This product should be handled as a cytotoxic agent, only by qualified healthcare personnel, and is strictly for hospital use under a physician's supervision.
Q: When can I expect order completion and quick dispatch?
A: Once your order is confirmed, shipped goods are dispatched swiftly from certified FOB ports, ensuring prompt delivery and efficient order completion.